Currently predicting for Tue, 28 May 2024

Trading levels for VSTM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 5.69 38.19 %
R2 5.22 26.78 %
R1 4.93 19.74 %
Current price: 4.12
Support S1 3.99 -3.07 %
S2 3.70 -10.12 %
S3 3.23 -21.52 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 4.12
Support S1 0 .
S2 0 .
S3 0 .

VSTM Predictions History

5 years ago
ss predicted that VSTM for 2018-11-09 is going $8.50 (-87.62%)

Rank:

5 years ago
ss predicted that VSTM for 2018-11-08 is going $5.50 (-92.17%)

Rank:

5 years ago
ss predicted that VSTM for 2018-10-26 is going $5.45 (-91.11%)

Rank:

5 years ago
ss predicted that VSTM for 2018-10-16 is going $7.80 (-88.50%)

Rank:

5 years ago
ss predicted that VSTM for 2018-10-08 is going $8.00 (-90.38%)

Rank:

5 years ago
ss predicted that VSTM for 2018-10-01 is going $9.20 (-89.43%)

Rank:

5 years ago
ss predicted that VSTM for 2018-09-28 is going $8.30 (-90.46%)

Rank:

5 years ago
anand15 predicted that VSTM for 2018-09-18 is going $9.20 (-90.70%)

Rank:

5 years ago
MoonJoin predicted that VSTM for 2018-09-18 is going $9.99 (-90.69%)

Rank:

5 years ago
Jay predicted that VSTM for 2018-09-18 is going $10.55 (-90.17%)

Rank:
Click to get the best stock tips daily for free!

About Verastem

Verastem Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The company also engages in developing RAMP 201, an adaptive two-part multicenter, parallel coho... VSTM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT